MESOBLAST LIMITED - Announcements

2.97%

$1.80

Market Cap $2.293B

Healthcare Biotechnology

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

MEMPHASYS LIMITED

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.

Announcements

Filter Results

All Price Sensitive Only

MSB	Mesoblast Maintains Momentum with FDA		12/06/25	188.95KB	Share
MSB	Becoming a substantial holder		06/06/25	443.55KB	Share
MSB	Becoming a substantial holder		05/06/25	2.02MB	Share
MSB	Becoming a substantial holder		03/06/25	1006.62KB	Share
MSB	Ceasing to be a substantial holder		03/06/25	1.37MB	Share
MSB	FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval	PRICE SENSITIVE	15/05/25	173.92KB	Share
MSB	Becoming a substantial holder		14/05/25	1.85MB	Share
MSB	Ceasing to be a substantial holder		09/05/25	1.27MB	Share
MSB	Becoming a substantial holder		08/05/25	1.97MB	Share
MSB	Ceasing to be a substantial holder		07/05/25	241.08KB	Share
MSB	Becoming a substantial holder		02/05/25	328.2KB	Share
MSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/25	440.59KB	Share
MSB	Initial Director's Interest Notice		29/04/25	230.8KB	Share
MSB	Director Appointment		29/04/25	182.59KB	Share
MSB	Appendix 3Y for Gregory George		24/04/25	256.27KB	Share
MSB	Mesoblast Extends Ryoncil Payer Coverage To 104M US Lives		17/04/25	184.56KB	Share
MSB	Notification of cessation of securities - MSB		14/04/25	12.8KB	Share
MSB	Notification regarding unquoted securities - MSB		14/04/25	14.47KB	Share
MSB	Application for quotation of securities - MSB		14/04/25	17.78KB	Share
MSB	Notification regarding unquoted securities - MSB		14/04/25	15.94KB	Share
MSB	Appendix 3Y - Silviu Itescu, Eric Rose and Philip Krause		08/04/25	284.42KB	Share
MSB	Notification regarding unquoted securities - MSB		08/04/25	16.66KB	Share
MSB	Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs	PRICE SENSITIVE	04/04/25	185.24KB	Share
MSB	Meeting Requested with FDA on Revascor Accelerated Approval		03/04/25	184.42KB	Share
MSB	First Children To Begin Treatment, Medicaid Covers Ryoncil	PRICE SENSITIVE	31/03/25	186.79KB	Share
MSB	Ryoncil Is Now Available For Purchase In The United States	PRICE SENSITIVE	27/03/25	188.31KB	Share
MSB	Ryoncil Published in All Four Major Drug Pricing Compendia		14/03/25	184.26KB	Share
MSB	CEO Presentation at ISCT North America		13/03/25	1.28MB	Share
MSB	Appendix 3Y for Gregory George		13/03/25	257.13KB	Share
MSB	CEO to Deliver Featured Presentation at ISCT North America		12/03/25	196.63KB	Share
MSB	Appendix 3Y and replacement Appendix 3X for Gregory George		07/03/25	415.95KB	Share
MSB	Appendix 3Y for Jane Bell		07/03/25	231.89KB	Share
MSB	Notification regarding unquoted securities - MSB		07/03/25	15.59KB	Share
MSB	Appendix 3Y for Eric Rose		07/03/25	272.69KB	Share
MSB	Mesoblast Added to S&P ASX200 Index		06/03/25	185.74KB	Share
MSB	ZSP: Arcadium Lithium PLC to be removed from the S&P/ASX 200	PRICE SENSITIVE	28/02/25	137.56KB	Share
MSB	Ryoncil Pricing Set and Available This Quarter	PRICE SENSITIVE	27/02/25	395.42KB	Share
MSB	Corporate Presentation and Half Year Financial Results	PRICE SENSITIVE	27/02/25	2.07MB	Share
MSB	Half Year Report and Accounts (including Appendix 4D)	PRICE SENSITIVE	27/02/25	1.77MB	Share
MSB	Mesoblast 2025 Half Year Financial Results Webcast		26/02/25	196.01KB	Share
MSB	Initial Director's Interest Notice		24/02/25	278.67KB	Share
MSB	Director Appointment		24/02/25	183.81KB	Share
MSB	Ryoncil Highlighted at Tandem Transplantation Meetings		14/02/25	270.03KB	Share
MSB	Change in substantial holding		07/02/25	211.96KB	Share
MSB	Ryoncil Commercial Launch Update and Product Pipeline	PRICE SENSITIVE	31/01/25	245.71KB	Share
MSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/25	427.9KB	Share
MSB	Cleansing Notice		24/01/25	231.28KB	Share
MSB	Application for quotation of securities - MSB		24/01/25	15.5KB	Share
MSB	Cleansing Notice		22/01/25	212.29KB	Share
MSB	Application for quotation of securities - MSB		22/01/25	15.66KB	Share
MSB	Ceasing to be a substantial holder		22/01/25	888.85KB	Share
MSB	Appendix 3Y for Eric Rose		21/01/25	238.03KB	Share
MSB	Cleansing Notice		20/01/25	211.95KB	Share
MSB	Application for quotation of securities - MSB		17/01/25	14.26KB	Share
MSB	Ceasing to be a substantial holder		16/01/25	558.83KB	Share
MSB	App 3Ys S Itescu J Bell W Burns P Facchina E Rose P Krause		16/01/25	386.75KB	Share
MSB	Notification regarding unquoted securities - MSB		16/01/25	22.99KB	Share
MSB	Notification of cessation of securities - MSB		15/01/25	13.35KB	Share
MSB	Notification regarding unquoted securities - MSB		15/01/25	15.63KB	Share
MSB	Notification regarding unquoted securities - MSB		15/01/25	16KB	Share
MSB	Notification regarding unquoted securities - MSB		15/01/25	14.43KB	Share
MSB	Application for quotation of securities - MSB		15/01/25	17.79KB	Share
MSB	Proposed issue of securities - MSB		14/01/25	14.85KB	Share
MSB	MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH	PRICE SENSITIVE	14/01/25	225.74KB	Share
MSB	Application for quotation of securities - MSB		10/01/25	15.77KB	Share
MSB	Application for quotation of securities - MSB		10/01/25	15.58KB	Share
MSB	Trading Halt	PRICE SENSITIVE	10/01/25	217.26KB	Share
MSB	Pause in Trading	PRICE SENSITIVE	10/01/25	114.73KB	Share
MSB	Change in substantial holding		10/01/25	1.48MB	Share
MSB	Becoming a substantial holder		09/01/25	1.05MB	Share
MSB	Proposed issue of securities - MSB		06/01/25	15.33KB	Share
MSB	Ceasing to be a substantial holder		06/01/25	776.81KB	Share
MSB	Becoming a substantial holder		27/12/24	1.89MB	Share
MSB	Becoming a substantial holder		24/12/24	1.22MB	Share
MSB	Appendix 3Y for Eric Rose		20/12/24	212.19KB	Share
MSB	Application for quotation of securities - MSB		20/12/24	16.45KB	Share
MSB	Cleansing Notice		20/12/24	231.42KB	Share
MSB	Mesoblast Webcast		19/12/24	185.1KB	Share
MSB	FDA Approves Mesoblast Ryoncil	PRICE SENSITIVE	19/12/24	218.24KB	Share
MSB	Mesoblast to be Added to Nasdaq Biotechnology Index		18/12/24	174.6KB	Share
MSB	Ceasing to be a substantial holder		18/12/24	815.79KB	Share
MSB	Change in substantial holding		16/12/24	220.6KB	Share
MSB	Material Announcement	PRICE SENSITIVE	05/12/24	112.64KB	Share
MSB	Pause in Trade	PRICE SENSITIVE	05/12/24	115.3KB	Share
MSB	FDA Grants Mesoblast RMAT Designation	PRICE SENSITIVE	05/12/24	196.86KB	Share
MSB	REVASCOR Improves Survival & Reduces Major Morbidity		03/12/24	205.8KB	Share
MSB	Becoming a substantial holder		21/11/24	1.87MB	Share
MSB	Results of Meeting		15/11/24	251.44KB	Share
MSB	Final Director's Interest Notice		15/11/24	265.82KB	Share
MSB	CEO Presentation to 2024 Annual General Meeting		15/11/24	2.24MB	Share
MSB	Mesoblast Chair Message to 2024 AGM		15/11/24	177.51KB	Share
MSB	Response to ASX Price Query	PRICE SENSITIVE	14/11/24	364.45KB	Share
MSB	Notification regarding unquoted securities - MSB		12/11/24	17.57KB	Share
MSB	Warrant Prospectus Related to Convertible Note Agreement		07/11/24	560.06KB	Share
MSB	Ceasing to be a substantial holder		05/11/24	1.22MB	Share
MSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/24	441.54KB	Share
MSB	Annual Report to Shareholders		17/10/24	4.25MB	Share
MSB	Notice of Annual General Meeting and Proxy Form		17/10/24	414.34KB	Share
MSB	Appendix 4G and Corporate Governance Statement		17/10/24	468.83KB	Share
MSB	Notification of cessation of securities - MSB		11/10/24	12.74KB	Share

MSB Mesoblast Maintains Momentum with FDA
12/06/25		188.95KB	Share
MSB Becoming a substantial holder
06/06/25		443.55KB	Share
MSB Becoming a substantial holder
05/06/25		2.02MB	Share
MSB Becoming a substantial holder
03/06/25		1006.62KB	Share
MSB Ceasing to be a substantial holder
03/06/25		1.37MB	Share
MSB FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
15/05/25	PRICE SENSITIVE	173.92KB	Share
MSB Becoming a substantial holder
14/05/25		1.85MB	Share
MSB Ceasing to be a substantial holder
09/05/25		1.27MB	Share
MSB Becoming a substantial holder
08/05/25		1.97MB	Share
MSB Ceasing to be a substantial holder
07/05/25		241.08KB	Share
MSB Becoming a substantial holder
02/05/25		328.2KB	Share
MSB Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25	PRICE SENSITIVE	440.59KB	Share
MSB Initial Director's Interest Notice
29/04/25		230.8KB	Share
MSB Director Appointment
29/04/25		182.59KB	Share
MSB Appendix 3Y for Gregory George
24/04/25		256.27KB	Share
MSB Mesoblast Extends Ryoncil Payer Coverage To 104M US Lives
17/04/25		184.56KB	Share
MSB Notification of cessation of securities - MSB
14/04/25		12.8KB	Share
MSB Notification regarding unquoted securities - MSB
14/04/25		14.47KB	Share
MSB Application for quotation of securities - MSB
14/04/25		17.78KB	Share
MSB Notification regarding unquoted securities - MSB
14/04/25		15.94KB	Share
MSB Appendix 3Y - Silviu Itescu, Eric Rose and Philip Krause
08/04/25		284.42KB	Share
MSB Notification regarding unquoted securities - MSB
08/04/25		16.66KB	Share
MSB Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs
04/04/25	PRICE SENSITIVE	185.24KB	Share
MSB Meeting Requested with FDA on Revascor Accelerated Approval
03/04/25		184.42KB	Share
MSB First Children To Begin Treatment, Medicaid Covers Ryoncil
31/03/25	PRICE SENSITIVE	186.79KB	Share
MSB Ryoncil Is Now Available For Purchase In The United States
27/03/25	PRICE SENSITIVE	188.31KB	Share
MSB Ryoncil Published in All Four Major Drug Pricing Compendia
14/03/25		184.26KB	Share
MSB CEO Presentation at ISCT North America
13/03/25		1.28MB	Share
MSB Appendix 3Y for Gregory George
13/03/25		257.13KB	Share
MSB CEO to Deliver Featured Presentation at ISCT North America
12/03/25		196.63KB	Share
MSB Appendix 3Y and replacement Appendix 3X for Gregory George
07/03/25		415.95KB	Share
MSB Appendix 3Y for Jane Bell
07/03/25		231.89KB	Share
MSB Notification regarding unquoted securities - MSB
07/03/25		15.59KB	Share
MSB Appendix 3Y for Eric Rose
07/03/25		272.69KB	Share
MSB Mesoblast Added to S&P ASX200 Index
06/03/25		185.74KB	Share
MSB ZSP: Arcadium Lithium PLC to be removed from the S&P/ASX 200
28/02/25	PRICE SENSITIVE	137.56KB	Share
MSB Ryoncil Pricing Set and Available This Quarter
27/02/25	PRICE SENSITIVE	395.42KB	Share
MSB Corporate Presentation and Half Year Financial Results
27/02/25	PRICE SENSITIVE	2.07MB	Share
MSB Half Year Report and Accounts (including Appendix 4D)
27/02/25	PRICE SENSITIVE	1.77MB	Share
MSB Mesoblast 2025 Half Year Financial Results Webcast
26/02/25		196.01KB	Share
MSB Initial Director's Interest Notice
24/02/25		278.67KB	Share
MSB Director Appointment
24/02/25		183.81KB	Share
MSB Ryoncil Highlighted at Tandem Transplantation Meetings
14/02/25		270.03KB	Share
MSB Change in substantial holding
07/02/25		211.96KB	Share
MSB Ryoncil Commercial Launch Update and Product Pipeline
31/01/25	PRICE SENSITIVE	245.71KB	Share
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25	PRICE SENSITIVE	427.9KB	Share
MSB Cleansing Notice
24/01/25		231.28KB	Share
MSB Application for quotation of securities - MSB
24/01/25		15.5KB	Share
MSB Cleansing Notice
22/01/25		212.29KB	Share
MSB Application for quotation of securities - MSB
22/01/25		15.66KB	Share
MSB Ceasing to be a substantial holder
22/01/25		888.85KB	Share
MSB Appendix 3Y for Eric Rose
21/01/25		238.03KB	Share
MSB Cleansing Notice
20/01/25		211.95KB	Share
MSB Application for quotation of securities - MSB
17/01/25		14.26KB	Share
MSB Ceasing to be a substantial holder
16/01/25		558.83KB	Share
MSB App 3Ys S Itescu J Bell W Burns P Facchina E Rose P Krause
16/01/25		386.75KB	Share
MSB Notification regarding unquoted securities - MSB
16/01/25		22.99KB	Share
MSB Notification of cessation of securities - MSB
15/01/25		13.35KB	Share
MSB Notification regarding unquoted securities - MSB
15/01/25		15.63KB	Share
MSB Notification regarding unquoted securities - MSB
15/01/25		16KB	Share
MSB Notification regarding unquoted securities - MSB
15/01/25		14.43KB	Share
MSB Application for quotation of securities - MSB
15/01/25		17.79KB	Share
MSB Proposed issue of securities - MSB
14/01/25		14.85KB	Share
MSB MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH
14/01/25	PRICE SENSITIVE	225.74KB	Share
MSB Application for quotation of securities - MSB
10/01/25		15.77KB	Share
MSB Application for quotation of securities - MSB
10/01/25		15.58KB	Share
MSB Trading Halt
10/01/25	PRICE SENSITIVE	217.26KB	Share
MSB Pause in Trading
10/01/25	PRICE SENSITIVE	114.73KB	Share
MSB Change in substantial holding
10/01/25		1.48MB	Share
MSB Becoming a substantial holder
09/01/25		1.05MB	Share
MSB Proposed issue of securities - MSB
06/01/25		15.33KB	Share
MSB Ceasing to be a substantial holder
06/01/25		776.81KB	Share
MSB Becoming a substantial holder
27/12/24		1.89MB	Share
MSB Becoming a substantial holder
24/12/24		1.22MB	Share
MSB Appendix 3Y for Eric Rose
20/12/24		212.19KB	Share
MSB Application for quotation of securities - MSB
20/12/24		16.45KB	Share
MSB Cleansing Notice
20/12/24		231.42KB	Share
MSB Mesoblast Webcast
19/12/24		185.1KB	Share
MSB FDA Approves Mesoblast Ryoncil
19/12/24	PRICE SENSITIVE	218.24KB	Share
MSB Mesoblast to be Added to Nasdaq Biotechnology Index
18/12/24		174.6KB	Share
MSB Ceasing to be a substantial holder
18/12/24		815.79KB	Share
MSB Change in substantial holding
16/12/24		220.6KB	Share
MSB Material Announcement
05/12/24	PRICE SENSITIVE	112.64KB	Share
MSB Pause in Trade
05/12/24	PRICE SENSITIVE	115.3KB	Share
MSB FDA Grants Mesoblast RMAT Designation
05/12/24	PRICE SENSITIVE	196.86KB	Share
MSB REVASCOR Improves Survival & Reduces Major Morbidity
03/12/24		205.8KB	Share
MSB Becoming a substantial holder
21/11/24		1.87MB	Share
MSB Results of Meeting
15/11/24		251.44KB	Share
MSB Final Director's Interest Notice
15/11/24		265.82KB	Share
MSB CEO Presentation to 2024 Annual General Meeting
15/11/24		2.24MB	Share
MSB Mesoblast Chair Message to 2024 AGM
15/11/24		177.51KB	Share
MSB Response to ASX Price Query
14/11/24	PRICE SENSITIVE	364.45KB	Share
MSB Notification regarding unquoted securities - MSB
12/11/24		17.57KB	Share
MSB Warrant Prospectus Related to Convertible Note Agreement
07/11/24		560.06KB	Share
MSB Ceasing to be a substantial holder
05/11/24		1.22MB	Share
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24	PRICE SENSITIVE	441.54KB	Share
MSB Annual Report to Shareholders
17/10/24		4.25MB	Share
MSB Notice of Annual General Meeting and Proxy Form
17/10/24		414.34KB	Share
MSB Appendix 4G and Corporate Governance Statement
17/10/24		468.83KB	Share
MSB Notification of cessation of securities - MSB
11/10/24		12.74KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.80		Change -0.055(2.97%)		Mkt cap ! $2.293B

Open	High	Low	Value	Volume
$1.84	$1.86	$1.77	$7.241M	4.018M

Buyers (Bids)

No.	Vol.	Price($)
3	25472	$1.80

Sellers (Offers)

Price($)	Vol.	No.
$1.81	1500	1

View Market Depth

No.	Vol.	Price($)
1	485	1.780
4	100773	1.770
2	25500	1.765
3	23000	1.760
7	44464	1.750

Price($)	Vol.	No.
1.805	1500	1
1.810	9500	1
1.820	4000	1
1.835	10000	1
1.840	5000	1

Last trade - 16.10pm 13/06/2025 (20 minute delay)

MSB (ASX) Chart

MESOBLAST LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories